The most commonly reported adverse events in Phase 2 and Phase 3 trials were gastrointestinal in nature, including nausea, diarrhea, vomiting, and constipation
BPC 157 has been investigated for its potential role in modulating nitric oxide signaling and vascular growth factor pathways
Supplementary information Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
NNMT Inhibitor Cellular Energy & Metabolic Optimization 5-Amino-1MQ is an innovative NNMT inhibitor that supports cellular energy production and metabolic function by modulating nicotinamide metabolismoffering a novel approach to metabolic health and vitality through targeted enzyme inhibition